Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2024, 33(3):175-182

Postprandial hypotension - a possible cardiovascular risk factor?

Peter Mitro
1. Kardiologická klinika UPJŠ LF a VÚSCH, a. s., Košice, Slovenská republika

Postprandial hypotension (PPH) is an excessive drop in blood pressure after eating, which can lead to clinical symptoms such as weakness, dizziness, falls, transient ischemic attacks of the central nervous system, angina pectoris or syncope. PPH is defined as a drop in systolic blood pressure (SBP) of 20 mmHg or more within two hours after a meal. PPH is more often observed in older patients, especially with an associated autonomic disorder (patients with diabetes mellitus, renal insufficiency, Parkinson's disease) but also long-lasting hypertension. Pathogenetic mechanisms of PPH include increased splanchnic pooling, impaired sympathetic nervous system, decreased postprandial baroreflex activity, and neurohumoral mechanisms. Attention is currently being paid mainly to the role of intestinal peptides in the development of PPH. Influencing the secretion of intestinal peptides is one of the promising methods for the treatment of postprandial hypotension.

Keywords: postprandial hypotension; syncope; gut peptides; somatostatin; glucagon-like peptide; glucose-dependent insulinotropic peptide

Published: March 1, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mitro P. Postprandial hypotension - a possible cardiovascular risk factor? Cardiology Letters. 2024;33(3):175-182.
Download citation

References

  1. Jansen RW and Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med. 1995;122:286-295. Go to original source...
  2. Mathias CJ. Postprandial hypotension. Pathophysiological mechanisms and clinical implications in different disorders. Hypertension. 1991;18:694-704. Go to original source...
  3. Madden KM, Feldman B, and Meneilly GS. Blood pressure measurement and the prevalence of postprandial hypotension. Clin Invest Med. 2019;42:E39-E46. Go to original source...
  4. Puisieux F, Bulckaen H, Fauchais AL, Drumez S, Salomez-Granier F, and Dewailly P. Ambulatory blood pressure monitoring and postprandial hypotension in elderly persons with falls or syncopes. J Gerontol A Biol Sci Med Sci. 2000;55:M535-540. Go to original source...
  5. Lagro J, Laurenssen NC, Schalk BW, Schoon Y, Claassen JA, and Olde Rikkert MG. Diastolic blood pressure drop after standing as a clinical sign for increased mortality in older falls clinic patients. J Hypertens. 2012;30:1195-1202. Go to original source...
  6. Mitro P, Feterik K, Cverckova A, and Trejbal D. Occurrence and relevance of postprandial hypotension in patients with essential hypertension. Wien Klin Wochenschr. 1999;111:320-325.
  7. Masuo K, Mikami H, Habara N, and Ogihara T. Orthostatic and postprandial blood pressure reduction in patients with essential hypertension. Clin Exp Pharmacol Physiol. 1991;18:155-161. Go to original source...
  8. Jansen RW, Kelly-Gagnon MM, and Lipsitz LA. Intraindividual reproducibility of postprandial and orthostatic blood pressure changes in older nursing-home patients: relationship with chronic use of cardiovascular medications. J Am Geriatr Soc. 1996;44:383-389. Go to original source...
  9. Vaitkevicius PV, Esserwein DM, Maynard AK, O'Connor FC, and Fleg JL. Frequency and importance of postprandial blood pressure reduction in elderly nursing-home patients. Ann Intern Med. 1991;115:865-870. Go to original source...
  10. Aronow WS and Ahn C. Association of postprandial hypotension with incidence of falls, syncope, coronary events, stroke, and total mortality at 29-month follow-up in 499 older nursing home residents. J Am Geriatr Soc. 1997 45:1051-1053. Go to original source...
  11. Freeman R, Young J, Landsberg L, and Lipsitz L. The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine. Neurology. 1996 47:1414-1420. Go to original source...
  12. Madden KM, Feldman B, and Meneilly GS. Baroreflex function and postprandial hypotension in older adults. Clin Auton Res. 2021;31:273-280. Go to original source...
  13. Mitro P, Feterik K, Lenartova M, Cverckova A, Curmova A, Rybarova E, et al. Humoral mechanisms in the pathogenesis of postprandial hypotension in patients with essential hypertension. Wien Klin Wochenschr. 2001;113:424-432.
  14. Linnestad P, Guldvog I, and Schrumpf E. Effects of dopamine and dopamine antagonists on postprandial release of pancreatic polypeptide in dogs and in healthy volunteers. Scand J Gastroenterol. 1983;18:81-85. Go to original source...
  15. Vaz M, Turner A, Kingwell B, Chin J, Koff E, Cox H, et al. Postprandial sympatho-adrenal activity: its relation to metabolic and cardiovascular events and to changes in meal frequency. Clin Sci (Lond). 1995;89:349-357. Go to original source...
  16. Kuchel O. Differential catecholamine responses to protein intake in healthy and hypertensive subjects. Am J Physiol. 1998;275:R1164-1173. Go to original source...
  17. Mathias CJ, da Costa DF, McIntosh CM, Fosbraey P, Bannister R, Wood SM, et al. Differential blood pressure and hormonal effects after glucose and xylose ingestion in chronic autonomic failure. Clin Sci (Lond). 1989;77:85-92. Go to original source...
  18. Sasaki E, Kitaoka H, and Ohsawa N. Postprandial hypotension in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1992;18:113-121. Go to original source...
  19. Jansen RW, Penterman BJ, van Lier HJ, and Hoefnagels WH. Blood pressure reduction after oral glucose loading and its relation to age, blood pressure and insulin. Am J Cardiol. 1987;60:1087-1091. Go to original source...
  20. Hoeldtke RD, Dworkin GE, Gaspar SR, Israel BC, and Boden G. Effect of the somatostatin analogue SMS-201-995 on the adrenergic response to glucose ingestion in patients with postprandial hypotension. Am J Med. 1989;86(6 Pt 1):673677. Go to original source...
  21. Borg MJ, Xie C, Rayner CK, Horowitz M, Jones KL, and Wu T. Potential for Gut Peptide-Based Therapy in Postprandial Hypotension. Nutrients. 2021;13:2826 Go to original source...
  22. Wu T, Trahair LG, Bound MJ, Deacon CF, Horowitz M, Rayner CK, et al. Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide? Diabet Med. 2015;32:595-600. Go to original source...
  23. Gentilcore D, Meyer JH, Rayner CK, Horowitz M, and Jones KL. Gastric distension attenuates the hypotensive effect of intraduodenal glucose in healthy older subjects. Am J Physiol Regul Integr Comp Physiol. 2008;29: R472-477. Go to original source...
  24. Trahair LG, Horowitz M, and Jones KL. Postprandial hypotension is associated with more rapid gastric emptying in healthy older individuals. J Am Med Dir Assoc. 2015;16:521-523. Go to original source...
  25. Trahair LG, Horowitz M, Stevens JE, Feinle-Bisset C, Standfield S, Piscitelli D, et al. Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetes. Diabetologia. 2015;58:1769-1778. Go to original source...
  26. Briant LJB, Reinbothe TM, Spiliotis I, Miranda C, Rodriguez B, and Rorsman P. delta-cells and beta-cells are electrically coupled and regulate alpha-cell activity via somatostatin. J Physiol. 2018;596:197-215. Go to original source...
  27. Aronow WS and Ahn C. Postprandial hypotension in 499 elderly persons in a long-term health care facility. J Am Geriatr Soc. 1994;42:930-932. Go to original source...
  28. Fisher AA, Davis MW, Srikusalanukul W, and Budge MM. Postprandial hypotension predicts all-cause mortality in older, low-level care residents. J Am Geriatr Soc. 2005;53:1313-1320. Go to original source...
  29. Jang A. Postprandial Hypotension as a Risk Factor for the Development of New Cardiovascular Disease: A Prospective Cohort Study with 36 Month Follow-Up in Community-Dwelling Elderly People. J Clin Med. 2020;9:345. Go to original source...
  30. Tabara Y, Okada Y, Uetani E, Nagai T, Igase M, Kido T, et al. Postprandial hypotension as a risk marker for asymptomatic lacunar infarction. J Hypertens. 2014;32:1084-1090; discussion 1090. Go to original source...
  31. Jenkins DJA, Sahye-Pudaruth S, Khodabandehlou K, Liang F, Kasmani M, Wanyan J, et al. Systematic review and metaanalysis examining the relationship between postprandial hypotension, cardiovascular events, and all-cause mortality. Am J Clin Nutr. 2022;116:663-671. Go to original source...
  32. Shibao CA and Biaggioni I. Management of Orthostatic Hypotension, Postprandial Hypotension, and Supine Hypertension. Semin Neurol. 2020 40:515-522. Go to original source...
  33. Trahair LG, Horowitz M, and Jones KL. Postprandial hypotension: a systematic review. J Am Med Dir Assoc. 2014;15:394-409. Go to original source...
  34. Kuipers HM, Jansen RW, Peeters TL, and Hoefnagels WH. The influence of food temperature on postprandial blood pressure reduction and its relation to substance-P in healthy elderly subjects. J Am Geriatr Soc. 1991;39:181-184. Go to original source...
  35. Trahair LG, Rajendran S, Visvanathan R, Chapman M, Stadler D, Horowitz M, et al. Comparative effects of glucose and water drinks on blood pressure and cardiac function in older subjects with and without postprandial hypotension. Physiol Rep. 2017;5:e13341 Go to original source...
  36. Furukawa K, Suzuki T, Ishiguro H, Morikawa H, Sonoda K, Iijima K, et al. Prevention of postprandial hypotension-related syncope by caffeine in a patient with long-standing diabetes mellitus. Endocr J. 2020;67:585-592. Go to original source...
  37. Wang B, Zhao J, Zhan Q, Wang R, Liu B, Zhou Y, et al. Acarbose for Postprandial Hypotension With Glucose Metabolism Disorders: A Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2021;8:663635. Go to original source...
  38. Jansen RW, Peeters TL, Lenders JW, van Lier HJ, v't Laar A, and Hoefnagels WH. Somatostatin analog octreotide (SMS 201-995) prevents the decrease in blood pressure after oral glucose loading in the elderly. J Clin Endocrinol Metab. 1989;68:752-756. Go to original source...
  39. Ludwig D, Terai S, Bruning A, and Stange EF. Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study. Aliment Pharmacol Ther. 1999;13:1119-1129. Go to original source...
  40. Jones KL, Rigda RS, Buttfield MDM, Hatzinikolas S, Pham HT, Marathe CS, et al. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes. Diabetes Obes Metab. 2019;21:1158-1167. Go to original source...
  41. Thazhath SS, Marathe CS, Wu T, Chang J, Khoo J, Kuo P, et al. The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes. 2016;65:269-275. Go to original source...
  42. Horowitz M, Rayner CK, Marathe CS, Wu T, Umapathysivam M, and Jones KL. Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. Diabetes Obes Metab. 2021;23:2411-2413. Go to original source...
  43. Kraaijenhof J, Muskiet MHA, Tonneijck L, Ouwens DM, Kramer MHH, van Raalte DH, et al. Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial. Diabetes Obes Metab. 2020;22:1847-1856. Go to original source...
  44. Wu T, Trahair LG, Little TJ, Bound MJ, Zhang X, Wu H, et al. Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 Diabetes. Diabetes Care. 2017;40:702-705. Go to original source...
  45. Stevens JE, Buttfield M, Wu T, Hatzinikolas S, Pham H, Lange K, et al. Effects of sitagliptin on gastric emptying of, and the glycaemic and blood pressure responses to, a carbohydrate meal in type 2 diabetes. Diabetes Obes Metab. 2020;2: 5158. Go to original source...
  46. Awosika A, Adabanya U, Millis RM, Omole AE, and Moon JH. Postprandial Hypotension: An Underreported Silent Killer in the Aged. Cureus. 2023;1:e35411. Go to original source...